|
![]() |
|||
|
||||
OverviewDiabetes Digital Health, Telehealth, and Artificial Intelligence explains how to develop and use the emerging technologies of digital health, telehealth, and artificial intelligence to address this important public health problem to deliver new hardware, software, and processes. The book explores trends in developing and deploying the three most important emerging technologies for diabetes: digital health, telehealth, and artificial intelligence. This book is essential to clinicians, scientists, engineers, industry professionals, regulators, and investors, offering the tools that will be used to create the next generation products to support a precision medicine approach to manage diabetes. According to the CDC, in the US there are 37 million people with diabetes and 96 million people with prediabetes. Diabetes triples the risk of myocardial infarction and stroke and is the leading cause of blindness, end stage renal failure, and amputations. The management of diabetes is becoming increasingly dominated by digital health tools consisting of wearable sensors, mobile applications providing decision support software, and wireless communication tools. Digital health provides new data streams that can be combined to create unique approaches for diabetes based on a precision medicine paradigm. Full Product DetailsAuthor: David C. Klonoff, M.D., FACP, FRCP (Edin), Fellow AIMBE (Clinical Professor of Medicine, U.C. San Francisco,Mills-Peninsula Medical Center, San Mateo, California, USA.) , David Kerr, MD, FRCP, FRCP (Edin) (Sutter Health Center for Health Systems Research, Santa Barbara, California, USA Rice University, Houston, Texas, USA) , Juan Espinoza, MD, FAAP (Stanley Manne Children’s Research Institute, Ann & Robert H. Lurie Children’s Hospital of Chicago, Chicago, Illinois, USA)Publisher: Elsevier Science Publishing Co Inc Imprint: Academic Press Inc Weight: 0.450kg ISBN: 9780443132445ISBN 10: 0443132445 Pages: 404 Publication Date: 08 July 2024 Audience: Professional and scholarly , Professional & Vocational Format: Paperback Publisher's Status: Active Availability: Manufactured on demand ![]() We will order this item for you from a manufactured on demand supplier. Table of ContentsReviewsAuthor InformationDr. David C. Klonoff, MD, FACP, FRCP (Edin), is an endocrinologist specializing in the development of diabetes technology. He is Medical Director of the Dorothy L. and James E. Frank Diabetes Research Institute of Mills-Peninsula Medical Center in San Mateo, California and a Clinical Professor of Medicine at UCSF, USA. Dr. Klonoff received the American Diabetes Association’s 2019 Outstanding Physician Clinician Award. He has received an FDA Director’s Special Citation Award for outstanding contributions related to diabetes technology. He is the Founding Editor-in-Chief of Journal of Diabetes Science and Technology and co-founded the Digital Diabetes Congress. He chairs the Scientific Advisory Board for the Texas A&M University Precise Advanced Technologies and Health Systems for Underserved Populations (PATHS-UP) Engineering Research Center. He is currently researching new devices and drugs for diabetes. Dr. Klonoff graduated from UC Berkeley and UCSF Medical School and did five years of internal medicine and endocrinology training at UCLA and UCSF. David Kerr MBChB, DM, FRCP, FRCPE, is a UK trained endocrinologist and has recently joined Sutter Health after spending almost a decade as a researcher/innovator in Santa Barbara, CA (https://www.davidkerrmd.com/). This began in 2014, with David’s appointment as Director of Research and Innovation at Sansum Diabetes Research Institute before moving to the Diabetes Technology Society as their lead for Digital Health last year. David has now joined Sutter Health as Senior Investigator, Diabetes Research and Digital Health Equity. David’s recent research has focused on offering wearable digital health technologies such as continuous glucose monitors to marginalized and historically excluded communities to help understand the potential value of real time physiological data. He has published more than 400 articles, commentaries and opinion pieces as well as co-authoring the first two books focusing on diabetes and digital health. David’s research has also included the use of “food-as-medicine for adults with or at-risk of diabetes. As part of this research, increasing participation in clinical research by traditionally hard to reach communities has been achieved through the creation of specially trained “Community Scientists from the same communities. David also has an adjunct position in the Dept of Computer Science and Electrical Engineering at Rice University in Houston Texas, and recently co-Chair of an NIDDK working group looking at the impact of innovation on furthering research into the heterogeneity of diabetes. You can follow David on ‘X’ at @godiabetesmd. Dr. Juan Espinoza is Director of the West Coast Consortium for Technology & Innovation Paediatrics) which is working with a $6.6 million FDA grant. Dr. Espinoza and Klonoff are co-Chairs of iCoDE, the multistakeholder project to create a standard for automatic integration of continuous glucose monitor data into the election health record. Tab Content 6Author Website:Countries AvailableAll regions |